{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-006468","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2022-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.937370+00:00","generated_at":"2026-06-27T16:29:51.924683+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ekso Bionics CEO Peurach resigns; Chairman Sherman becomes CEO","bullets":["CEO Jack Peurach resigns effective Jan 21, 2022; receives severance of 9 months salary, $187,250 lump sum, and RSU acceleration.","Chairman Steven Sherman appointed CEO effective Jan 22; will receive equity award in lieu of $453K annual cash salary.","Scott Davis promoted to President and COO from EVP Strategy and Corporate Development.","Board appoints new committee chairs; Stanley Stern becomes Lead Independent Director.","Press release notes record Q4 2021 revenue and momentum in inpatient rehab and industrial sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-006468","json":"https://secwatch.observer/filing/0001104659-22-006468.json","markdown":"https://secwatch.observer/filing/0001104659-22-006468.md","text":"https://secwatch.observer/filing/0001104659-22-006468.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/tm223985d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:29:51.924683+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26ddba0d39","claim":"Stanley Stern was appointed as Lead Independent Director at EKSO BIONICS HOLDINGS, INC..","evidence_excerpt":"Board member Stanley Stern has been designated the Board’s lead independent director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"designated"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"},{"claim_id":"2d9ef81a72","claim":"Steven Sherman was appointed as Chief Executive Officer at EKSO BIONICS HOLDINGS, INC..","evidence_excerpt":"the Company’s Board appointed Steven Sherman, who currently serves as the Chairman of the Board, to become Chief Executive Officer of the Company effective January 22, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"65a2aa23c2","claim":"Jack Peurach resigned as President, Chief Executive Officer and a director at EKSO BIONICS HOLDINGS, INC..","evidence_excerpt":"Jack Peurach, the President, Chief Executive Officer and a director of Ekso Bionics Holdings, Inc. (the “Company”), notified the Company of his intention to resign as an officer and member of the Board of Directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President, Chief Executive Officer and a director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}